Impact of the phased abolition of co‐payments on the utilisation of selected prescription medicines in Wales

E-ISSN： 1099-1050|27|1|236-243

ISSN： 1057-9230

Source： HEALTH ECONOMICS, Vol.27, Iss.1, 2018-01, pp. : 236-243

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prescription drug co-payments and cost-related medication underuse

Health Economics, Policy and Law, Vol. 3, Iss. 1, 2008-01 ,pp. : 51-67

Cambridge University Press

Access to resources Recommend Favorite

Co-payments in the NHS: an analysis of the normative arguments

Health Economics, Policy and Law, Vol. 5, Iss. 2, 2010-04 ,pp. : 225-246

Cambridge University Press

Access to resources Recommend Favorite

The determinants of out-of-pocket payments: evidence from selected hospitals in Ankara, Turkey

By Yildirim Julide Yilmaz Erdogan Korucu Nebile

Applied Economics Letters, Vol. 18, Iss. 12, 2011-08 ,pp. : 1159-1162

Routledge Ltd

Access to resources Recommend Favorite

Strategic complementarities and social transfers: how do PROGRESA payments impact nonbeneficiaries?

By Barrientos Armando Sabatés-Wheeler Rachel

Applied Economics, Vol. 43, Iss. 23, 2011-09 ,pp. : 3175-3185

Routledge Ltd

Access to resources Recommend Favorite

Giving Mom a Break: The Impact of Higher EITC Payments on Maternal Health

By Evans William N. Garthwaite Craig L.

American Economic Journal: Economic Policy, Vol. 6, Iss. 2, 2014-05 ,pp. : 258-290

American Economic Association

Access to resources Recommend Favorite